Summary:
We are currently looking for participants who have a documented diagnosis of Idiopathic Pulmonary Fibrosis (IPF) and are 40 years or older.
The study will be investigating whether a study treatment called CSL312 will be effective over a 14 week treatment period in patients who have IPF.
Qualified Participants Must:
• Have been diagnosed with IPF
•
Are 40 years or older
Qualified Participants May Receive:
During the study you will be asked to:
- Come to on-site clinical visits to receive study treatment (complimentary transportation may be provided if needed)
- Provide blood samples and urine samples
- Complete spirometry testing
- At the end of the study, you will be asked to attend a final follow-up visit over the phone.
- $150 upon completion of the screening visit
- $50 upon completion of the subsequent visit
- Ask your study team about transportation and home health services at no cost to you